针灸联合中药复方治疗老年轻度认知障碍的随机对照试验方案
主要结局为MoCA评分,次要结局为MMSE和事件相关电位,采用意向性分析,旨在评估针灸与中药复方联合治疗的疗效及叠加或协同效应。
要点
- 针灸联合益肾颗粒治疗老年MCI的多中心随机对照试验方案
- 四组析因设计可分离针灸与中药的独立及联合效应
- 主要结局为MoCA,次要结局为MMSE和事件相关电位
核心结论
- 该试验将评估针灸、益肾颗粒单用及联合治疗老年MCI的疗效,并分析两疗法的叠加或协同效应。
主要发现
- 原文为试验方案,尚未报告疗效结果。
关键数值与推荐
- 主要结局采用蒙特利尔认知评估(MoCA)评分。
- 次要结局采用简易精神状态检查(MMSE)和事件相关电位(ERP)评分。
- 针灸治疗每周2次共8周,随后每周1次共4周。
- 中药治疗每日服用颗粒剂共12周,前8周标准剂量,后4周中等剂量。
- 评估在基线、干预开始后第8周和第12周进行;随访在干预结束后第12、24和36周采用MoCA评估。
临床怎么用
- 若试验证实联合治疗有效,可为老年MCI患者提供针灸联合益肾颗粒的治疗选择。
局限性
- 原文为试验方案,尚未提供疗效数据,结论需待试验完成后确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mild cognitive impairment (MCI) is known as a transitional status between normal cognitive function and Alzheimer's disease (AD). Acupuncture and Chinese herbal medicines (CHMs) are considered to be beneficial to patients with cognitive impairment. However, it is still unknown whether the combination of the two therapies could optimize the therapeutic effect for MCI. This trial is aimed to evaluate the therapeutic effects of acupuncture and the herbal formula Yishen Granule (YSG) for elderly patients with MCI. METHODS/DESIGN: This is a multi-sited, patient-blinded, randomized controlled trial (RCT). Two hundred and forty eligible patients will be randomly divided into four groups: A. acupuncture with YSG, B. acupuncture with placebo herbal medicine, C. sham acupuncture with YSG or D. sham acupuncture with placebo herbal medicine. Acupuncture treatment will be given twice a week for 8 weeks and then once a week for 4 weeks. The herbal treatment patients will be given granules daily for 12 weeks, 8 weeks of standard-dose followed by 4 weeks of mid-dose. The primary outcome is scored by the Montreal Cognitive Assessment (MoCA). The secondary outcomes will be scored by the Mini-Mental State Examination (MMSE) and event-related potential (ERP). All the assessments will be conducted at baseline, and at the eighth and 12th week after intervention starts. The follow-up assessments will be performed with the MoCA in the 12th, 24th, and 36th weeks after intervention ends. Intention-to-treat (ITT) analysis will be used in this RCT. DISCUSSION: This RCT will provide us information on the effect of treating MCI patients with only acupuncture, herbal formula as well as the combination of both. The additive effect or synergistic effect of acupuncture and Chinese herbal formula will then be analyzed. TRIAL REGISTRATION: This trial is registered with ChiCTR-INR-17011569 on 5 June 2017, and has been approved by the Ethics Committee of Shanghai Municipal Hospital of Traditional Chinese Medicine (2017SHL-KY-05).
引用
- Chen Y, Zhang W, Wu H, et al. Combination of acupuncture and Chinese herbal formula for elderly adults with mild cognitive impairment: protocol for a randomized controlled trial. Trials. 2019. PMID: 30744676. doi:10.1186/s13063-019-3212-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。